Nuveen, LLC Biogen Inc. Transaction History

Nuveen, LLC

$315 Billion
Q1 2025

A detailed history of Nuveen, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Nuveen, LLC holds 146,431 shares of BIIB stock, worth $18.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

146,431

Holding current value

$18.2 Million

% of portfolio

0.01%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$133.43 - $153.27 $19.5 Million - $22.4 Million	146,431 New	146,431 $20 Million

Others Institutions Holding BIIB

# of Institutions

1,009

Shares Held

124M

Call Options Held

1.69M

Put Options Held

2.34M

Vanguard Group Inc Valley Forge, PA

17M
Shares

$2.12 Billion
0.04% of portfolio
Primecap Management CO Pasadena, CA

15.9M
Shares

$1.98 Billion
1.84% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$1.81 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.4M
Shares

$920 Million
0.05% of portfolio
Wellington Management Group LLP Boston, MA

4.67M
Shares

$581 Million
0.13% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Account